联合检测凝血指标与CEA对结肠癌的诊断价值及诊断意义
The Diagnostic Value and Significance of Combined Detection of Coagulation Indicators and CEA for Colon Cancer
摘要: 目的:本研究旨在评估纤维蛋白原/前白蛋白比值(Fibrinogen-Prealbumin Ratio, FPR)联合纤维蛋白原(Fibrinogen, FIB)、D-二聚体(D-dimer, D-D)及癌胚抗原(Carcinoembryonic antigen, CEA)检测对结肠癌的诊断价值。通过多指标联合检测策略,系统分析这些血清标志物在结肠癌筛查和诊断中的临床应用潜力。方法:本研究选取2021年10月至2024年10月期间在北华大学附属医院接受诊治的140例患者作为研究对象。病例组纳入70例经病理学确诊并接受手术治疗的结肠癌患者,对照组纳入70例经结肠镜检查确诊的结肠良性病变患者。对两组患者术前的FPR、FIB、D-D、CEA水平及术后病理资料进行差异性分析,并绘制受试者工作特征曲线(ROC)。结果:1. 在结肠癌组患者中,血清FPR、FIB、D-D、CEA水平均高于对照组,且这种差异在统计学上具有显著性(Z = 7.469, P < 0.001; Z = 8.485, P < 0.001; Z = 8.201, P < 0.001; Z = 8.905, P < 0.001)。2. 对结肠癌患者的病理资料进行分析发现:TNM分期、淋巴结转移与FIB有关(U = 393.00, P = 0.010; U = 438.50, P = 0.041),肿瘤大小与FPR有关(U = 416.00, P = 0.024)。3. FPR、FIB、D-D、CEA 及联合检测的曲线下面积分别为0.812、0.780、0.765、0.844、0.880。结论:联合检测FPR、FIB、D-D和CEA,可显著提升结肠癌诊断效能。
Abstract: Objective: This study aims to evaluate the fibrinogen-prealbumin Ratio (FPR) combined with Fibrinogen (FIB) and D-dimer. The diagnostic value of D-D and Carcinoembryonic antigen (CEA) detection for colon cancer. Through the multi-index combined detection strategy, the clinical application potential of these serum markers in the screening and diagnosis of colon cancer was systematically analyzed. Method: In this study, 140 patients who were diagnosed and treated at the Affiliated Hospital of Beihua University from October 2021 to October 2024 were selected as the research subjects. The case group included 70 patients with colon cancer who were pathologically diagnosed and received surgical treatment, while the control group included 70 patients with benign colon lesions diagnosed by colonoscopy. The differences in the levels of FPR, FIB, D-D, CEA before the operation and the postoperative pathological data of the two groups of patients were analyzed, and the receiver operating characteristic curve (ROC) was drawn. Result: 1. The levels of serum FPR, FIB, D-D and CEA in the colon cancer group were higher than those in the control group, and the differences were statistically significant (Z = 7.469, P < 0.001; Z = 8.485, P < 0.001; Z = 8.201, P < 0.001; Z = 8.905, P < 0.001). 2. Analysis of the pathological data of patients with colon cancer revealed that TNM stage and lymph node metastasis were related to FIB (U = 393.00, P = 0.010; U = 438.50, P = 0.041), and the tumor size was related to FPR (U = 416.00, P = 0.024). 3. The areas under the curves of FPR, FIB, D-D, CEA and combined detection were 0.812, 0.780, 0.765, 0.844 and 0.880 respectively. Conclusion: The combined detection of FPR, FIB, D-D and CEA can significantly improve the diagnostic efficacy of colon cancer.
文章引用:张超凡, 敬舒. 联合检测凝血指标与CEA对结肠癌的诊断价值及诊断意义[J]. 临床个性化医学, 2025, 4(3): 553-559. https://doi.org/10.12677/jcpm.2025.43380

参考文献

[1] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[2] 张昱, 张金卓. 结直肠癌早期筛查及其诊断生物标志物的研究进展[J]. 中国医学创新, 2023, 20(12): 169-173.
[3] Lopez, N. and Peterson, C. (2016) Advances in Biomarkers: Going beyond the Carcinoembryonic Antigen. Clinics in Colon and Rectal Surgery, 29, 196-204. [Google Scholar] [CrossRef] [PubMed]
[4] 吴子林, 涂登燕, 谢阳阳. 血清DR-70联合CEA, CA199对结直肠癌的诊断价值[J]. 临床与病理杂志, 2022, 42(7): 1552-1557.
[5] Li, X., Guo, D., Chu, L., Huang, Y., Zhang, F., Li, W., et al. (2019) potential Diagnostic Value of Combining Inflammatory Cell Ratios with Carcinoembryonic Antigen for Colorectal Cancer. Cancer Management and Research, 11, 9631-9640. [Google Scholar] [CrossRef] [PubMed]
[6] 胡顺霖, 李敏, 叶江锋, 等. 血清肿瘤标志物检测在结肠癌辅助诊断中的价值[J]. 实用临床医药杂志, 2019, 23(5): 35-37.
[7] 刘荫华, 姚宏伟, 周斌, 等. 美国肿瘤联合会结直肠癌分期系统(第8版)更新解读[J]. 中国实用外科杂志, 2017, 37(1): 6-9.
[8] Jelski, W. and Mroczko, B. (2020) Biochemical Markers of Colorectal Cancer—Present and Future. Cancer Management and Research, 12, 4789-4797. [Google Scholar] [CrossRef] [PubMed]
[9] Gao, Y., Wang, J., Zhou, Y., Sheng, S., Qian, S.Y. and Huo, X. (2018) Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer. Scientific Reports, 8, Article 2732. [Google Scholar] [CrossRef] [PubMed]
[10] 韩建蓉, 吴丽娜, 刘蕊. 探讨肿瘤标志物在结直肠癌患者中的诊断价值[J]. 实用检验医师杂志, 2013, 5(3): 147-150.
[11] 胡红永, 汤建林, 李玉莹, 等. 肿瘤标志物 CEA, CA19-9, CA242 联检在结直肠癌患者诊断中的应用[J]. 国际放射医学核医学杂志, 2010, 34(2): 97-99.
[12] 牧慧, 王颢, 于恩达, 等. 结直肠癌相关炎症标志物和抗炎治疗的研究进展[J]. 结直肠肛门外科, 2024, 30(3): 397-400.
[13] 陈夕浪, 吴开春. 结直肠癌生物标志物的研究进展[J]. 内科急危重症杂志, 2023, 29(1): 1-5.
[14] 侯双双, 张革红, 陈路锋, 等. 基于白蛋白的炎性-营养标志物对结直肠癌患者预后评估价值的研究进展[J]. 消化肿瘤杂志(电子版), 2024, 16(2): 208-215.
[15] 汪晓东, 刘丹, 吕东昊, 等. 结直肠癌血清纤维蛋白原和炎性介质, 肿瘤标志物的术前诊断价值[J]. 肿瘤防治研究, 2010, 37(5): 566-569.
[16] 李付涛, 卢业才. 血浆纤维蛋白原与前白蛋白比值和中性粒细胞与淋巴细胞比值对结直肠癌的术前诊断价值研究[J]. 医学信息, 2022, 35(6): 132-134.